Cargando…

BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13

The deubiquitinase BAP1 (BRCA1-associated protein 1) is associated with BAP1 tumor predisposition syndrome (TPDS). BAP1 is a tumor suppressor gene whose alterations in cancer are commonly caused by gene mutations leading to protein loss of function. By CRISPR-Cas, we have generated mutations in ubh-...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Fernández, Carmen, Jha, Sweta, Aliagas, Elisabet, Holmberg, Carina I., Nadal, Ernest, Cerón, Julián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047281/
https://www.ncbi.nlm.nih.gov/pubmed/36980270
http://dx.doi.org/10.3390/cells12060929
_version_ 1785013881667584000
author Martínez-Fernández, Carmen
Jha, Sweta
Aliagas, Elisabet
Holmberg, Carina I.
Nadal, Ernest
Cerón, Julián
author_facet Martínez-Fernández, Carmen
Jha, Sweta
Aliagas, Elisabet
Holmberg, Carina I.
Nadal, Ernest
Cerón, Julián
author_sort Martínez-Fernández, Carmen
collection PubMed
description The deubiquitinase BAP1 (BRCA1-associated protein 1) is associated with BAP1 tumor predisposition syndrome (TPDS). BAP1 is a tumor suppressor gene whose alterations in cancer are commonly caused by gene mutations leading to protein loss of function. By CRISPR-Cas, we have generated mutations in ubh-4, the BAP1 ortholog in Caenorhabditis elegans, to model the functional impact of BAP1 mutations. We have found that a mimicked BAP1 cancer missense mutation (UBH-4 A87D; BAP1 A95D) resembles the phenotypes of ubh-4 deletion mutants. Despite ubh-4 being ubiquitously expressed, the gene is not essential for viability and its deletion causes only mild phenotypes without affecting 20S proteasome levels. Such viability facilitated an RNAi screen for ubh-4 genetic interactors that identified rpn-9, the ortholog of human PSMD13, a gene encoding subunit of the regulatory particle of the 26S proteasome. ubh-4[A87D], similarly to ubh-4 deletion, cause a synthetic genetic interaction with rpn-9 inactivation affecting body size, lifespan, and the development of germ cells. Finally, we show how ubh-4 inactivation sensitizes animals to the chemotherapeutic agent Bortezomib, which is a proteasome inhibitor. Thus, we have established a model to study BAP1 cancer-related mutations in C. elegans, and our data points toward vulnerabilities that should be studied to explore therapeutic opportunities within the complexity of BAP1 tumors.
format Online
Article
Text
id pubmed-10047281
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100472812023-03-29 BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13 Martínez-Fernández, Carmen Jha, Sweta Aliagas, Elisabet Holmberg, Carina I. Nadal, Ernest Cerón, Julián Cells Article The deubiquitinase BAP1 (BRCA1-associated protein 1) is associated with BAP1 tumor predisposition syndrome (TPDS). BAP1 is a tumor suppressor gene whose alterations in cancer are commonly caused by gene mutations leading to protein loss of function. By CRISPR-Cas, we have generated mutations in ubh-4, the BAP1 ortholog in Caenorhabditis elegans, to model the functional impact of BAP1 mutations. We have found that a mimicked BAP1 cancer missense mutation (UBH-4 A87D; BAP1 A95D) resembles the phenotypes of ubh-4 deletion mutants. Despite ubh-4 being ubiquitously expressed, the gene is not essential for viability and its deletion causes only mild phenotypes without affecting 20S proteasome levels. Such viability facilitated an RNAi screen for ubh-4 genetic interactors that identified rpn-9, the ortholog of human PSMD13, a gene encoding subunit of the regulatory particle of the 26S proteasome. ubh-4[A87D], similarly to ubh-4 deletion, cause a synthetic genetic interaction with rpn-9 inactivation affecting body size, lifespan, and the development of germ cells. Finally, we show how ubh-4 inactivation sensitizes animals to the chemotherapeutic agent Bortezomib, which is a proteasome inhibitor. Thus, we have established a model to study BAP1 cancer-related mutations in C. elegans, and our data points toward vulnerabilities that should be studied to explore therapeutic opportunities within the complexity of BAP1 tumors. MDPI 2023-03-18 /pmc/articles/PMC10047281/ /pubmed/36980270 http://dx.doi.org/10.3390/cells12060929 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Martínez-Fernández, Carmen
Jha, Sweta
Aliagas, Elisabet
Holmberg, Carina I.
Nadal, Ernest
Cerón, Julián
BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13
title BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13
title_full BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13
title_fullStr BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13
title_full_unstemmed BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13
title_short BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13
title_sort bap1 malignant pleural mesothelioma mutations in caenorhabditis elegans reveal synthetic lethality between ubh-4/bap1 and the proteasome subunit rpn-9/psmd13
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047281/
https://www.ncbi.nlm.nih.gov/pubmed/36980270
http://dx.doi.org/10.3390/cells12060929
work_keys_str_mv AT martinezfernandezcarmen bap1malignantpleuralmesotheliomamutationsincaenorhabditiselegansrevealsyntheticlethalitybetweenubh4bap1andtheproteasomesubunitrpn9psmd13
AT jhasweta bap1malignantpleuralmesotheliomamutationsincaenorhabditiselegansrevealsyntheticlethalitybetweenubh4bap1andtheproteasomesubunitrpn9psmd13
AT aliagaselisabet bap1malignantpleuralmesotheliomamutationsincaenorhabditiselegansrevealsyntheticlethalitybetweenubh4bap1andtheproteasomesubunitrpn9psmd13
AT holmbergcarinai bap1malignantpleuralmesotheliomamutationsincaenorhabditiselegansrevealsyntheticlethalitybetweenubh4bap1andtheproteasomesubunitrpn9psmd13
AT nadalernest bap1malignantpleuralmesotheliomamutationsincaenorhabditiselegansrevealsyntheticlethalitybetweenubh4bap1andtheproteasomesubunitrpn9psmd13
AT ceronjulian bap1malignantpleuralmesotheliomamutationsincaenorhabditiselegansrevealsyntheticlethalitybetweenubh4bap1andtheproteasomesubunitrpn9psmd13